Cargando…

Finding NMO

Detalles Bibliográficos
Autor principal:	Daneman, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173348/ https://www.ncbi.nlm.nih.gov/pubmed/28018944 http://dx.doi.org/10.1212/NXI.0000000000000313

Ejemplares similares

Neurodegeneration in MS and NMO: The Eye and the Blood
por: Petzold, Axel, et al.
Publicado: (2011)

Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy?
por: Fujihara, Kazuo, et al.
Publicado: (2014)

Therapy of NMO spectrum disorders
por: Biswas, Atanu, et al.
Publicado: (2015)

Neuromyelitis optica (NMO) and autoimmune thyroiditis
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2015)

Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD
por: Zeka, Bleranda, et al.
Publicado: (2016)

Autoimmune thyroiditis associated with neuromyelitis optica (NMO)
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2015)

Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Disease: CHANCE(NMO) Study
por: Hümmert, Martin W., et al.
Publicado: (2022)

Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
por: Borisow, Nadja, et al.
Publicado: (2018)

Where Do AQP4 Antibodies Fit in the Pathogenesis of NMO?
por: Kinoshita, Makoto, et al.
Publicado: (2012)

NMO-IgG: A Specific Biomarker for Neuromyelitis Optica
por: Weinshenker, Brian G., et al.
Publicado: (2006)

Wallenda-Nmo Axis Regulates Growth via Hippo Signaling
por: Wang, Xianping, et al.
Publicado: (2021)

Wernicke’s Encephalopathy Precipitated by Area Postrema Syndrome of NMO-SD
por: Anuradha, Mahto, et al.
Publicado: (2023)

Vitamin D and Demyelinating Diseases: Neuromyelitis Optica (NMO) and Multiple Sclerosis (MS)
por: Rodney, Cady, et al.
Publicado: (2020)

Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO)
por: Vaknin-Dembinsky, Adi, et al.
Publicado: (2016)

3D-DIR for early differential diagnostic and prognostic evaluation of NMO
por: Wang, Yanbing, et al.
Publicado: (2016)

Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO
por: Higuchi, Osamu, et al.
Publicado: (2016)

Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO
por: Gelfand, Jeffrey M., et al.
Publicado: (2014)

Identification of geraldol as an inhibitor of aquaporin-4 binding by NMO-IgG
por: Wang, Jie, et al.
Publicado: (2020)

COVID-19 infection in NMO/SD patients: a French survey
por: Zeidan, Sinéad, et al.
Publicado: (2020)

Classifying the antibody-negative NMO syndromes: Clinical, imaging, and metabolomic modeling
por: Yeo, Tianrong, et al.
Publicado: (2019)

An Atypical Presentation of Chronic Inflammatory Myelin Degeneration in Neuromyelitis Optica (NMO)
por: Allu, Sai Vishnu Vardhan, et al.
Publicado: (2023)

Unmasking and provoking severe disease activity in a patient with NMO spectrum disorder
por: Kornberg, Michael D., et al.
Publicado: (2015)

Mitoxantrone in NMO Spectrum Disorder in a Large Multicenter Cohort in French Caribbean
por: Chaumont, Hugo, et al.
Publicado: (2023)

Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study
por: Valentino, Paola, et al.
Publicado: (2016)

Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO
por: Kitley, Joanna, et al.
Publicado: (2015)

Review of approved NMO therapies based on mechanism of action, efficacy and long-term effects
por: Brod, Staley A.
Publicado: (2020)

Comparative Analysis for the Presence of IgG Anti-Aquaporin-1 in Patients with NMO-Spectrum Disorders
por: Sánchez Gomar, Ismael, et al.
Publicado: (2016)

Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis
por: Saini, Harleen, et al.
Publicado: (2013)

Importance of Regular and Maintenance Therapy Adherence in Neuromyelitis Optica (NMO): Lessons from a Repeating Relapse Case
por: Miao, Jing, et al.
Publicado: (2018)

Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury
por: Asavapanumas, Nithi, et al.
Publicado: (2014)

An Optimized Immunohistochemistry Technique Improves NMO-IgG Detection: Study Comparison with Cell-Based Assays
por: Höftberger, Romana, et al.
Publicado: (2013)

IV/IT hUC-MSCs Infusion in RRMS and NMO: A 10-Year Follow-Up Study
por: Lu, Zhengjuan, et al.
Publicado: (2020)

NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness
por: Mizrachi, Tehila, et al.
Publicado: (2018)

Hematopoietic Stem Cell Transplantation in Neuromyelitis Optica-Spectrum Disorders (NMO-SD): State-of-the-Art and Future Perspectives
por: Ceglie, Giulia, et al.
Publicado: (2020)

Butchering knives and hafting at the Late Middle Paleolithic open-air site of Nahal Mahanayeem Outlet (NMO), Israel
por: Martin-Viveros, Juan Ignacio, et al.
Publicado: (2023)

A Novel approach using O-CVP to treat paraneoplastic NMO spectrum disorder associated with follicular lymphoma
por: Palmer, David Antony, et al.
Publicado: (2022)

Systemic Lupus Erythematosus (SLE) Complicated by Neuromyelitis Optica (NMO – Devic’s Disease): Clinic-Pathological Report and Review of the Literature
por: Adawi, Mohammad, et al.
Publicado: (2014)

Mild COVID-19 infection in an NMO patient treated with tocilizumab: a confirmation of anti-IL-6 protective role?
por: Mantero, Vittorio, et al.
Publicado: (2020)

Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Diseases: COPANMO(G)-Study
por: Hümmert, Martin W., et al.
Publicado: (2023)

Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)
por: Hümmert, Martin W, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6vrtrrgvjepgsmockdnbg8nqkg